Published in Vaccine Weekly, May 3rd, 2006
GeneThera's Purivax, is a multi-resin anion exchange chromatography system that dramatically improves biological purity and viral titer of recombinant adenovirus and AAV vectors. Purivax, completely eliminates toxic side effects associated with adenoviruses and AAV vectors thereby making it possible to quickly develop highly immunogenic and safe recombinant DNA...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.